Effects of Bone Marrow Mesenchymal Stem Cells on Hematopoietic Recovery and Acute Graft-Versus-Host Disease in Murine Allogeneic Umbilical Cord Blood Transplantation Model

Cell Biochemistry and Biophysics

Volumn 70, Issue 1, 2014, Pages 115-122

  Li, Zhen Yu ^a   Wang, Chun Qing ^a   Lu, Guang ^a   Pan, Xiu Ying ^a   Xu, Kai Lin ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Acute graft versus host disease; Allogeneic umbilical cord blood transplantation; Hematopoietic recovery; Mesenchymal; Stem cells

Indexed keywords

MURINAE; MUS;

ADVERSE EFFECTS; ALLOTRANSPLANTATION; ANIMAL; BONE MARROW CELL; C57BL MOUSE; CELL SEPARATION; CULTURE TECHNIQUE; CYTOLOGY; FEMALE; FETUS BLOOD; GRAFT VS HOST DISEASE; HEMATOPOIESIS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; MOUSE; SURVIVAL; TRANSPLANTATION;

ANIMALS; BONE MARROW CELLS; CELL CULTURE TECHNIQUES; CELL SEPARATION; FEMALE; FETAL BLOOD; GRAFT VS HOST DISEASE; HEMATOPOIESIS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; SURVIVAL ANALYSIS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84906212940     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-014-9866-y     Document Type: Article

References (20)

1. Gluckman, E., & Rocha, V. (2009). Cord blood transplantation: State of the art. Haematologica, 94, 451-454.
2. Frassoni, F., Gualandi, F., Podestà, M., et al. (2008). Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: A phase I/II study. The Lancet Oncology, 9, 812-814.
3. Szabolcs, P., & Niedzwiecki, D. (2008). Immune reconstitution in children after unrelated cord blood transplantation. Biology of Blood and Marrow Transplantation, 14(1 suppl 1), 66-72.
4. Komanduri, K. V., John, L. S., de Lima, M., et al. (2007). Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing. Blood, 110(13), 4543-4551.
5. Takami, A., Mochizuki, K., Asakura, H., et al. (2005). High incidence of cytomegalovirus reactivation in adult recipients of an unrelated cord blood transplant. Haematologica, 90(9), 1290-1292.
6. Kurtzberg, J., Prasad, V. K., Carter, S. L., et al. (2008). Results of the cord blood transplantation study (COBLT): Clinical outcome of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies. Blood, 112(10), 4318-4327.
7. Gluckman, E. (2000). Current status of umbilical cord blood hematopoietic stem cell transplantation. Experimental Hematology, 28(11), 1197-1205.
8. Marktel, S., Magnani, Z., Cicer, F., et al. (2003). Immunologic potential of donor lymphocytes expressing a suicide gene for early immune reconstitution after hematopoietic T-cell-depleted stem cell transplantation. Blood, 101(4), 1290-1298.
9. Cohen, J. L., Boyer, O., Thomas-Vaslin, V., et al. (1999). Suicide gene-mediated modulation of GVHD. Leukaemia & Lymphoma, 34(5-6), 473-480.
10. Peister, A., Mellad, J. A., Larson, B. L., et al. (2004). Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood, 103, 1662-1668.
11. Cooke, K. R., Kobzik, L., Martin, T. R., et al. (1996). An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin. Blood, 88, 3230-3239.
12. Jiang, X. X., Zhang, Y., Liu, B., et al. (2005). Human mesenchymal stem cells inhibit differentiation and function of monocyte derived dendritic cells. Blood, 105(10), 4120-4126.
13. Di Nicola, M., Carlo-Stella, C., Magni, M., et al. (2002). Human bone marrow stormal cells suppress T lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood, 99(10), 3838-3843.
14. Krampera, M., Cosmi, L., Angeli, R., et al. (2006). Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells, 24, 386-398.
15. Sudres, M., Norol, F., & Trenado, A. (2006). Bone marrow mesenchymal stem cells suppress lymphocyte proliferation in vitro but fail to prevent graft-versus-host disease in mice. Journal of Immunology, 176, 7761-7767.
16. Bernardo, M. E., Ball, L. M., & Cometa, A. M. (2011). Co-infusion of ex vivo-expanded, parental MSCs prevents life-threatening acute GVHD, but does not reduce the risk of graft failure in pediatric patients undergoing allogeneic umbilical cord blood transplantation. Bone Marrow Transplantation, 46, 200-207.
17. Meuleman, N., Tondreau, T., & Ahmad, I. (2009). Infusion of mesenchymal stromal cells can aid hematopoietic recovery following allogeneic hematopoietic stem cell myeloablative transplant: A pilot study. Stem Cells and Development, 18, 1247-1252.
18. Ringdén, O. (2009). Mesenchymal stromal cells as first-line treatment of graft failure after hematopoietic stem cell transplantation. Stem Cells and Development, 18, 1243-1246.
19. Kim, D. H., Yoo, K. H., Yim, Y. S., et al. (2006). Cotransplanted bone marrow derived mesenchymal stem cells (MSC) enhanced engraftment of hematopoietic stem cells in a MSC-dose dependent manner in NOD/SCID mice. Journal of Korean Medical Science, 21, 1000-1004.
20. Joo, S. Y., Cho, K. A., Jung, Y. J., et al. (2010). Mesenchymal stromal cells inhibit graft-versus-host disease of mice in a dose-dependent manner. Cytotherapy, 12, 361-370.